Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

University of Arkansas Medical Center

InstitutionResearch output, impact & collaborations

University of Arkansas Medical Center is a research organisation in Little Rock, US. OpenAlex records 4,274 works and 251,120 citations for it. 889 researchers list it as their most recent affiliation.

4,274
Works
251,120
Citations
889
Researchers
70
Avg h-index

How has University of Arkansas Medical Center's publication output changed over time?

ScholarIQpublication output · 1996–2019

Output grew0% over the shown period — from 1 works in 1996 to 1 in 2019.

1
1
1
1
1
2
1
3
1
199620022004200920112013201620172019

Who are the most-cited researchers behind University of Arkansas Medical Center?

ScholarIQtop researchers by citations
1
Bradley C. Martin · Opioid Use Disorder Treatment
261 works11,906 citations

What are the most-cited papers on University of Arkansas Medical Center?

ScholarIQmost cited works
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
New England Journal of Medicine. 20112,398 CitationsOPEN ACCESS
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Marcel Verheij, Ron Bose, Xin Lin, Bei Yao, W. David Jarvis, Steven Grant, Michael J. Birrer, Éva Szabó, Leonard I. Zon, John Kyriakis, Adriana Haimovitz‐Friedman, Zvi Fuks, Richard Kolesnick
Nature. 19961,796 Citations
Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015
Anuj Shah, Corey J. Hayes, Bradley C. Martin
S183158886. 2017968 CitationsOPEN ACCESS
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine, George A. Dominguez, Je‐In Youn, Andrew V. Kossenkov, Sridevi Mony, Kevin Alicea-Torres, Evgenii N. Tcyganov, Ayumi Hashimoto, Yulia Nefedova, Cindy Lin, Simona Partlová, Alfred L. Garfall, Dan T. Vogl, Xiaowei Xu, Stella C. Knight, George Malietzis, Gui Han Lee, Evgeniy Eruslanov, Steven Μ. Albelda, Xianwei Wang, Jawahar L. Mehta, Meenakshi Bewtra, Anil K. Rustgi, Neil Hockstein, Robert Witt, Gregory A. Masters, Brian Nam, Denis A. Smirnov, Manuel A. Sepúlveda, Dmitry I. Gabrilovich
S2764653179. 2016810 Citations
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas Reid, Mario M. Leitão, Helen E. Michael, Philip J. DiSaia, Larry J. Copeland, William T. Creasman, Frederick B. Stehman, Mark F. Brady, Robert A. Burger, J.T. Thigpen, Michael J. Birrer, Steven Waggoner, David H. Moore, Katherine Y. Look, Wui-Jin Koh, Bradley J. Monk
The Lancet. 2017686 CitationsOPEN ACCESS

How much of the research on University of Arkansas Medical Center is open access?

ScholarIQopen access share
50%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
8%
Bronze
25%
Closed
50%

Related on ScholarIQ

Multiple Myeloma Research and Treatments
Top Topic
Innovations in Medical Education
Top Topic
Congenital Heart Disease Studies
Top Topic
Respiratory Support and Mechanisms
Top Topic
Urological Disorders and Treatments
Top Topic
Epilepsy research and treatment
Top Topic
470M+ articles · free account